While some TSGs are already known to play a key role in HCC pathogenesis, including the cell cycle regulator CDKN2A [12–14], some less well-characterized targets have been found selectively silenced in specific iClust HCC subtypes. Here, CDKN2A is linked to hepatocellular carcinoma.